Header cover image

Israeli (TA) Pharma Industry Analysis

UpdatedMar 24, 2024
DataAggregated Company Financials
Companies8
  • 7D6.3%
  • 3M24.4%
  • 1Y-18.5%
  • YTDn/a

In the last week, the Pharma industry is up 6.3%, with InterCure up 12%. Meanwhile, Purple Biotech actually underperformed within the industry, shrinking 6.9% in the last week. However, the industry is down 18% over the past year.

Industry Valuation and Performance

Has the Israeli Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 25 Mar 2024₪715.5m₪972.3m-₪207,898,236.0017.8x-3.4x0.7x
Wed, 21 Feb 2024₪690.0m₪972.3m-₪213,137,092.0015.8x-3.2x0.7x
Fri, 19 Jan 2024₪588.3m₪972.3m-₪214,702,073.0011.8x-2.7x0.6x
Sun, 17 Dec 2023₪576.5m₪972.3m-₪213,044,415.0010x-2.7x0.6x
Tue, 14 Nov 2023₪569.9m₪958.8m-₪210,798,030.009x-2.7x0.6x
Thu, 12 Oct 2023₪624.3m₪958.8m-₪212,860,194.0011.9x-2.9x0.7x
Sat, 09 Sep 2023₪664.9m₪956.9m-₪207,958,818.0013.8x-3.2x0.7x
Mon, 07 Aug 2023₪647.5m₪918.8m-₪125,778,589.008.3x-5.1x0.7x
Wed, 05 Jul 2023₪673.6m₪918.8m-₪126,698,691.008.4x-5.3x0.7x
Fri, 02 Jun 2023₪759.5m₪906.2m-₪127,815,462.0010.3x-5.9x0.8x
Sun, 30 Apr 2023₪816.5m₪887.2m-₪121,334,672.008.5x-6.7x0.9x
Tue, 28 Mar 2023₪788.2m₪815.6m-₪70,627,454.0011.7x-11.2x1x
Thu, 23 Feb 2023₪925.8m₪815.6m-₪71,431,336.0013.9x-13x1.1x
Sat, 21 Jan 2023₪1.0b₪739.7m-₪55,273,425.0017.1x-18.5x1.4x
Mon, 19 Dec 2022₪1.1b₪739.7m-₪56,373,675.0020x-19.4x1.5x
Wed, 16 Nov 2022₪1.3b₪689.4m-₪64,593,413.0032.9x-20.2x1.9x
Fri, 14 Oct 2022₪1.3b₪689.4m-₪61,267,872.0031.2x-21x1.9x
Sun, 11 Sep 2022₪1.4b₪785.2m-₪110,458,872.0030.3x-12.7x1.8x
Tue, 09 Aug 2022₪1.7b₪731.4m-₪116,190,006.0044x-14.3x2.3x
Thu, 07 Jul 2022₪1.6b₪731.4m-₪120,001,253.0045x-13.2x2.2x
Sat, 04 Jun 2022₪1.7b₪731.4m-₪116,819,591.0042.3x-15x2.4x
Mon, 02 May 2022₪1.8b₪669.4m-₪122,884,925.0037.9x-14.3x2.6x
Wed, 30 Mar 2022₪2.0b₪598.9m-₪110,679,432.0048.9x-17.7x3.3x
Fri, 25 Feb 2022₪1.8b₪598.9m-₪111,987,017.0045.6x-15.7x2.9x
Sun, 23 Jan 2022₪1.9b₪598.9m-₪96,216,770.0051.2x-20.2x3.2x
Tue, 21 Dec 2021₪2.0b₪559.8m-₪170,072,379.0048x-11.5x3.5x
Thu, 18 Nov 2021₪2.2b₪561.8m-₪158,075,436.0029.9x-14x3.9x
Sat, 16 Oct 2021₪2.3b₪522.6m-₪146,956,547.0029x-15.5x4.4x
Mon, 13 Sep 2021₪2.4b₪515.1m-₪150,674,423.5028.2x-15.9x4.6x
Wed, 11 Aug 2021₪2.3b₪499.0m-₪147,462,423.5026.8x-15.5x4.6x
Sun, 06 Jun 2021₪2.7b₪466.6m-₪189,880,366.5028.8x-14.2x5.8x
Price to Earnings Ratio

-10.9x


Total Market Cap: ₪2.1bTotal Earnings: -₪189,880,366.50Total Revenue: ₪466.6mTotal Market Cap vs Earnings and Revenue0%0%0%
Israeli Pharma Industry Price to Earnings3Y Average -12x202220232024
Current Industry PE
  • Investors are pessimistic on the Israeli Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.3x is higher than the industry's current PS ratio of 0.74x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 28% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Israeli Pharma compare with similar industries?

IL Market3.77%
Healthcare-0.067%
Pharma6.31%
Pharma6.31%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
INCR InterCure₪8.1711.9%
+₪39.6m
5.3%PE17.8x
SEMG Seach Medical Group₪2.055.1%
+₪3.4m
7.0%PS0.5x
CSURE-M Cannassure Therapeutics₪10.0044.9%
+₪2.6m
59.7%PS0.3x
PNAX Panaxia Labs Israel₪120.6016.1%
+₪2.5m
-31.4%PS0.7x
TKUN Tikun Olam-Cannbit Pharmaceuticals₪0.288.2%
+₪1.7m
-53.4%PS0.4x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PNAX

₪120.60

Panaxia Labs Israel

7D

16.1%

1Y

-31.4%

NXGN

₪1.06

Nextgen Biomed

7D

0.2%

1Y

-71.2%

PPBT

₪0.26

Purple Biotech

7D

-6.9%

1Y

-64.6%

TKUN

₪0.28

Tikun Olam-Cannbit Pharmaceuticals

7D

8.2%

1Y

-53.4%

INCR

₪8.17

InterCure

7D

11.9%

1Y

5.3%

CSURE-M

₪10.00

Cannassure Therapeutics

7D

44.9%

1Y

59.7%